4.4 Article

A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs

Journal

JOURNAL OF GENERAL VIROLOGY
Volume 102, Issue 3, Pages -

Publisher

MICROBIOLOGY SOC
DOI: 10.1099/jgv.0.001579

Keywords

guinea pig; cytomegalovirus; CMV; epithelial cell; glycoprotein gB; antibody neutralization; congenital infection; virus tropism; pentamer complex; CMV vaccine

Funding

  1. NIH institutes NIAID [R01AI098984, R01AI100933]
  2. NICHD [R01HD090065]

Ask authors/readers for more resources

The research suggests that multiple strains of human cytomegalovirus can cause congenital cytomegalovirus. Studies on small animal models have shown that gB vaccines perform well in terms of protection, but there are differences in compatibility with different viral strains. Pentamer complex antibodies have a significant impact on neutralization of non-fibroblast cell infection.
Multiple strains of human cytomegalovirus (HCMV) can cause congenital cytomegalovirus (cCMV) by primary or secondary infection. The viral gB glycoprotein is a leading vaccine candidate, essential for infection of all cell-types, and immunodominant antibody target. Guinea pig cytomegalovirus (GPCMV) is the only small animal model for cCMV. Various gB vaccines have shown efficacy but studies have utilized truncated gB and protection against prototype strain 22122 with preferential tropism to fibroblasts despite encoding a gH-based pentamer complex for non-fibroblast infection. A highly cell-associated novel strain of GPCMV (TAMYC) with 99% identity in gB sequence to 22122 exhibited preferred tropism to epithelial cells. An adenovirus vaccine encoding full-length gB (AdgB) was highly immunogenic and partially protected against 22122 strain challenge in vaccinated animals but not when challenged with TAMYC strain. GPCMV studies with AdgB vaccine sera on numerous cell-types demonstrated impaired neutralization (NA(50)) compared to fibroblasts. GPCMV-convalescent sera including pentamer complex antibodies increased virus neutralization on non-fibroblasts and anti-gB depletion from GPCMV-convalescent sera had minimal impact on epithelial cell neutralization. GPCMV(PC+) 22122-convalescent animals challenged with TAMYC exhibited higher protection compared to AdgB vaccine. Overall, results suggest that antibody response to both gB and PC are important components of a GPCMV vaccine.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available